BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 32215548)

  • 1. Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?
    Monteleone G; Ardizzone S
    J Crohns Colitis; 2020 Sep; 14(9):1334-1336. PubMed ID: 32215548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak: A Survey From the European Crohn's and Colitis Organization.
    D'Amico F; Danese S; Peyrin-Biroulet L;
    Gastroenterology; 2020 Jul; 159(1):14-19.e3. PubMed ID: 32360567
    [No Abstract]   [Full Text] [Related]  

  • 3. Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers.
    Stallmach A; Sturm A; Blumenstein I; Helwig U; Koletzko S; Lynen P; Schmidt C; Dignass A; Kucharzik T;
    Z Gastroenterol; 2020 Oct; 58(10):982-1002. PubMed ID: 33036052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting.
    Rubin DT; Abreu MT; Rai V; Siegel CA;
    Gastroenterology; 2020 Jul; 159(1):6-13.e6. PubMed ID: 32272113
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020).
    Marín-Jiménez I; Zabana Y; Rodríguez-Lago I; Marín L; Barreiro-de Acosta M; Esteve M;
    Gastroenterol Hepatol; 2020; 43(7):408-413. PubMed ID: 32419715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor
    Nowak JK; Lindstrøm JC; Kalla R; Ricanek P; Halfvarson J; Satsangi J
    Gastroenterology; 2020 Sep; 159(3):1151-1154.e2. PubMed ID: 32413354
    [No Abstract]   [Full Text] [Related]  

  • 7. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.
    Rubin DT; Feuerstein JD; Wang AY; Cohen RD
    Gastroenterology; 2020 Jul; 159(1):350-357. PubMed ID: 32283100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel.
    Din S; Kent A; Pollok RC; Meade S; Kennedy NA; Arnott I; Beattie RM; Chua F; Cooney R; Dart RJ; Galloway J; Gaya DR; Ghosh S; Griffiths M; Hancock L; Hansen R; Hart A; Lamb CA; Lees CW; Limdi JK; Lindsay JO; Patel K; Powell N; Murray CD; Probert C; Raine T; Selinger C; Sebastian S; Smith PJ; Tozer P; Ustianowski A; Younge L; Samaan MA; Irving PM
    Gut; 2020 Oct; 69(10):1769-1777. PubMed ID: 32513653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19.
    Siegel CA; Christensen B; Kornbluth A; Rosh JR; Kappelman MD; Ungaro RC; Johnson DF; Chapman S; Wohl DA; Mantzaris GJ
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S769-S773. PubMed ID: 33085972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take Stock.
    D'Amico F; Danese S; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2689-2700. PubMed ID: 32777550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers].
    Stallmach A; Sturm A; Blumenstein I; Helwig U; Koletzko S; Lynen P; Schmidt C; Dignaß A; Kucharzik T;
    Z Gastroenterol; 2020 Jul; 58(7):672-692. PubMed ID: 32659830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease.
    Scucchi L; Neri B; Sarmati L; Mossa M; Sena G; Massoud R; Petruzziello C; Musumeci M; Marafini I; Calabrese E; Lolli E; Bernardini S; Andreoni M; Monteleone G; Biancone L
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2418-2424. PubMed ID: 33755981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low frequency of COVID-19 in inflammatory bowel diseases.
    Marafini I; Salvatori S; Sena G; Calabrese E; Biancone L; Monteleone G
    Dig Liver Dis; 2020 Nov; 52(11):1234-1235. PubMed ID: 32601036
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.
    Bezzio C; Armuzzi A; Furfaro F; Ardizzone S; Milla M; Carparelli S; Orlando A; Caprioli FA; Castiglione F; Viganò C; Ribaldone DG; Zingone F; Monterubbianesi R; Imperatore N; Festa S; Daperno M; Scucchi L; Ferronato A; Pastorelli L; Balestrieri P; Ricci C; Cappello M; Felice C; Fiorino G; Saibeni S;
    Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1432-1441. PubMed ID: 34694009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and immunomodulation in IBD.
    Neurath MF
    Gut; 2020 Jul; 69(7):1335-1342. PubMed ID: 32303609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy.
    Viganò C; Massironi S; Pirola L; Cristoferi L; Fichera M; Bravo M; Mauri M; Redaelli AE; Dinelli ME; Invernizzi P
    Inflamm Bowel Dis; 2020 Oct; 26(11):e138-e139. PubMed ID: 32949238
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical Trials for Inflammatory Bowel Disease: Global Guidance During the COVID-19 Pandemic.
    Reinisch W; Danese S; Peyrin-Biroulet L; Loftus EV
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S815-S819. PubMed ID: 32520311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of inflammatory bowel disease and COVID-19.
    Sultan K; Mone A; Durbin L; Khuwaja S; Swaminath A
    World J Gastroenterol; 2020 Oct; 26(37):5534-5542. PubMed ID: 33088153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon.
    Verstockt B; Verstockt S; Abdu Rahiman S; Ke BJ; Arnauts K; Cleynen I; Sabino J; Ferrante M; Matteoli G; Vermeire S
    J Crohns Colitis; 2021 Mar; 15(3):485-498. PubMed ID: 32915959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of Endoscopy in Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.
    Navaneethan U; Lourdusamy D; LehnerNoguera V; Shen B
    Inflamm Bowel Dis; 2020 Sep; 26(10):e118-e119. PubMed ID: 32676646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.